Syneron Medical Ltd (ELOS) Posts Q3 EPS of $0.03, Sales Top Expectations
Tweet
Share
E-mailGet Alerts ELOS Hot Sheet
Join SI Premium – FREE
Syneron Medical Ltd (NASDAQ: ELOS) reported Q3 EPS of $0.03, which may not compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $57 million versus the consensus estimate of $50.66 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AbbVie (ABBV) Tops Q1 EPS by 4c, Raises Guidance
- Riverview Bancorp, Inc. (RVSB) Misses Q4 EPS by 17c
- Colgate-Palmolive (CL) tops Q1 expectations, raises sales guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
